# Buprenorphine + Naloxone

## Suboxone 8/2mg

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | OSUB                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 適應症     | Treatment of opioid dependence.                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 用法用量   | Sublingual film: Heroin or short-acting opioid dependency: Day 1 induction dose: Initial: Buprenorphine 2 mg/naloxone 0.5 mg or buprenorphine 4 mg/naloxone 1 mg; may titrate dose, based on control of acute withdrawal symptoms, in buprenorphine 2 to 4 mg/naloxone 0.5 to 1 mg increments approximately every 2 hours up to a total dose of buprenorphine 8 mg/naloxone 2 mg. Day 2 induction dose: Up to buprenorphine 16 mg/naloxone 4 mg once daily |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 禁忌       | Hypersensitivity to buprenorphine, naloxone, or any component of the formulation                                                                                                                                                                                                                                                                                                                                                                           |
| 副作用     | Central nervous system: Headache (36%), withdrawal syndrome (25%; placebo 37%), pain (22%) Dermatologic: Diaphoresis (14%) Gastrointestinal: Glossodynia (film), oral hypoesthesia (film), oral mucosa erythema (film)                                                                                                                                                                                                                                     |
| 孕期建議   | No (limited) human data – probably compatible                                                                                                                                                                                                                                                                                                                                                                                                              |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                        |

